.After F2G's first try to obtain a brand-new class of antifungal to market was hindered by the FDA, ...
.Moderna has actually pledged to reduce R&D costs by $1.1 billion by 2027. The choice to retract ...
.Just four months after Sanofi wager $80 million in beforehand cash on Fulcrum Therapies' losmapimod...
.Cancer provider Oncternal Rehabs is folding all its medical tests and also laying off team, switchi...
.Roche is actually storing out hopes that its injectable weight problems prospect can at some point ...
.Novo Nordisk has raised the cover on a period 1 trial of its own oral amylin as well as GLP-1 recep...
.Just a handful of brief weeks after succeeding an FDA Fast lane tag for its own investigational BTK...
.Not long after a favorable data decline for Eli Lilly's efsitora alfa, the Indianapolis-based busin...
.BridgeBio Pharma is actually slashing its own genetics therapy spending plan and drawing back from ...
.GSK's effort to cultivate the initial injection for herpes simplex virus (HSV) has actually finishe...